Apotea AB (publ) (APOTEA)

NASDAQ Stockholm | Retail | Online pharmacy and healthcare products
Free
No email, no account, no signup.
Pulling latest news for Apotea AB (publ)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ Stockholm
Type
Retail
Sector
Online pharmacy and healthcare products
Market Cap
$772M
We're already tracking Apotea AB (publ) — here are the latest events we've registered

Recent News

  • On April 29, 2026, Apotea reported its Q1 2026 results, showing a 10.5% increase in net revenue to SEK 1,937.2 million and an operating profit of SEK 101.3 million. The company highlighted increased capacity utilization at its automated logistics center in Varberg and the soft launch of its beauty and health assortment in Norway.
Want to know how this news affects Apotea AB (publ)? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Apotea AB (publ) will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
Apotea AB (publ) (APOTEA)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.